Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:36 pm Sale |
2023-12-31 | 13G | Sigilon Therapeutics, Inc. SGTX |
Flagship Ventures Fund V, L.P. | 0 0.000% |
-797,721 (Position Closed) |
Filing History |
| 2023-08-14 4:30 pm Purchase |
2023-08-11 | 13D | Sigilon Therapeutics, Inc. SGTX |
ELI LILLY & Co LLY |
100 100.000% |
100 (New Position) |
Filing History |
| 2023-07-07 4:33 pm Purchase |
2023-06-28 | 13D | Sigilon Therapeutics, Inc. SGTX |
ELI LILLY & Co LLY |
1,008,830 40.300% |
797,719 (+377.87%) |
Filing History |
| 2022-07-08 4:56 pm Sale |
2022-06-30 | 13G | Sigilon Therapeutics, Inc. SGTX |
BlackRock Inc. BLK |
82,007 3.300% |
-51,574 (-38.61%) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Sigilon Therapeutics, Inc. SGTX |
BlackRock Inc. BLK |
133,581 5.400% |
133,581 (New Position) |
Filing History |
| 2021-02-16 5:06 pm Purchase |
2020-12-31 | 13G | Sigilon Therapeutics, Inc. SGTX |
Flagship Ventures Fund V, L.P. | 797,721 33.200% |
797,721 (New Position) |
Filing History |
| 2021-02-12 4:31 pm Purchase |
2020-12-31 | 13G | Sigilon Therapeutics, Inc. SGTX |
ELI LILLY & Co LLY |
211,111 8.800% |
211,111 (New Position) |
Filing History |